Detailed Information
Cited 2 time in 
Cited 0 time in 
Cited 0 time in
Metadata Downloads
Lazertinib, a 3rd generation EGFR-TKI, in patients with EGFR-TKI resistant NSCLC: Updated results of phase I/II Study.
- Authors
- Ahn, Myung-Ju; Han, Ji-Youn; Kim, Sang-We; Lee, Ki Hyeong; Kim, Dong-Wan; Lee, Yun-Gyoo; Cho, Eun Kyung; Lee, Gyeong-won; Lee, Jong-Seok; Kim, Joo-Hang; Kim, Jin-Soo; Min, Young Joo; Lee, Sung Sook; Shin, Sang Won; Kim, HyeRyun; Hong, Min Hee; Ahn, Jin Seok; Lee, Seoung Oh; Kim, Sohee; Cho, Byoung Chul
- Issue Date
- 20-May-2019
- Publisher
- AMER SOC CLINICAL ONCOLOGY
- Citation
- JOURNAL OF CLINICAL ONCOLOGY, v.37, no.15
- Journal Title
- JOURNAL OF CLINICAL ONCOLOGY
- Volume
- 37
- Number
- 15
- ISSN
- 0732-183X
- Files in This Item
- There are no files associated with this item.
- Appears in
Collections - 의과대학 > 의학과 > 1. Journal Articles
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
Related Researcher
- Cho, Eun Kyung
- College of Medicine (Department of Medicine)